MULTIMERIC PATTERN OF PLASMA AND PLATELET VON-WILLEBRAND-FACTOR IS NORMAL IN UREMIC PATIENTS

被引:18
作者
CASTAMAN, G
RODEGHIERO, F
LATTUADA, A
LAGRECA, G
MANNUCCI, PM
机构
[1] SAN BORTOLO HOSP,DEPT HEMATOL & HEMOPHILIA,I-36100 VICENZA,ITALY
[2] SAN BORTOLO HOSP,CTR THROMBOSIS,I-36100 VICENZA,ITALY
[3] SAN BORTOLO HOSP,DEPT NEPHROL,I-36100 VICENZA,ITALY
[4] MAGGIORE HOSP,IRCCS,ANGELO BIANCHI BONOMI HEMOPHILIA & THROMBOSIS CTR,MILAN,ITALY
[5] UNIV MILAN,MILAN,ITALY
关键词
VON WILLEBRAND FACTOR; BLEEDING TIME; ACQUIRED BLEEDING DIATHESIS; UREMIA;
D O I
10.1002/ajh.2830440409
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Several studies have reported increased von Willebrand factor (vWF) levels in plasma of uremic patients, with a normal multimeric pattern. Two recent studies, however, have shown a reduction of the larger multimers of plasma vWF and one has also found low levels of platelet vWF in uremic patients with prolonged bleeding time (BT). We have measured plasma and platelet vWF and analyzed its multimeric pattern in 20 uremic patients, 11 with a prolonged BT and 9 with a normal BT. For Plasma vWF, no difference for vWF:Ag, RiCof, and ristocetin-induced platelet agglutination was found between the two groups with normal and prolonged BT. The multimeric pattern of plasma vWF, as evaluated by densitometric scanning of the electrophoretic gels, was normal in both groups. For platelet vWF, vWF:Ag and RiCof content was similar in the two groups. The multimeric pattern was indistinguishable from that of normal platelets. In conclusion, our study does not confirm the presence of a structural defect of plasma vWF and the reduction of platelet vWF content in uremia. (C) 1993 Wiley-Liss, Inc.
引用
收藏
页码:266 / 269
页数:4
相关论文
共 24 条
[1]   PLATELET DYSFUNCTION IN UREMIA - MULTIFACETED DEFECT PARTIALLY CORRECTED BY DIALYSIS [J].
DIMINNO, G ;
MARTINEZ, J ;
MCKEAN, ML ;
DELAROSA, J ;
BURKE, JF ;
MURPHY, S .
AMERICAN JOURNAL OF MEDICINE, 1985, 79 (05) :552-559
[2]  
ESCOLAR G, 1990, BLOOD, V76, P1336
[3]  
GRALNICK HR, 1988, AM J MED, V85, P806
[4]  
HERMANN RP, 1977, BRIT MED J, V1, P1602
[5]   TREATMENT OF THE BLEEDING TENDENCY IN UREMIA WITH CRYOPRECIPITATE [J].
JANSON, PA ;
JUBELIRER, SJ ;
WEINSTEIN, MJ ;
DEYKIN, D .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (23) :1318-1322
[6]   BLEEDING IN RENAL-FAILURE - POSSIBLE CAUSE [J].
KAZATCHKINE, M ;
SULTAN, Y ;
CAEN, JP ;
BARIETY, J .
BMJ-BRITISH MEDICAL JOURNAL, 1976, 2 (6036) :612-615
[7]   CONJUGATED ESTROGENS FOR THE MANAGEMENT OF BLEEDING ASSOCIATED WITH RENAL-FAILURE [J].
LIVIO, M ;
MANNUCCI, PM ;
VIGANO, G ;
MINGARDI, G ;
LOMBARDI, R ;
MECCA, G ;
REMUZZI, G .
NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (12) :731-735
[8]  
MANNUCCI PM, 1988, BLOOD, V71, P65
[9]   DEAMINO-8-D-ARGININE VASOPRESSIN SHORTENS THE BLEEDING-TIME IN UREMIA [J].
MANNUCCI, PM ;
REMUZZI, G ;
PUSINERI, F ;
LOMBARDI, R ;
VALSECCHI, C ;
MECCA, G ;
ZIMMERMAN, TS .
NEW ENGLAND JOURNAL OF MEDICINE, 1983, 308 (01) :8-12
[10]  
MOAKE JL, 1985, BLOOD, V65, P1232